A randomized controlled trial of low-dose aspirin in women at risk from pre-eclampsia

International Journal of Gynecology and Obstetrics

Volumn 60, Issue 2, 1998, Pages 129-135

  Byaruhanga, R N ^a   Chipato, T ^b   Rusakaniko, S ^b  

^a St Francis Hospital Uganda   (Uganda)

^b UNIVERSITY OF ZIMBABWE   (Zimbabwe)

Author keywords

Low dose aspirin; Pregnancy induced hypertension

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO;

ADULT; ARTICLE; BIRTH WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; ORAL DRUG ADMINISTRATION; PERINATAL MORTALITY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032007979     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(97)00257-9     Document Type: Article

References (20)

1. [1] Hypertensive disorders of pregnancy. WHO technical report series, 1987;758.
2. [2] Zuspan F. New concepts in the understanding of hypertensive disease during pregnancy. Clin. Perinatol. 1991;18:653-659.
3. [3] Sibai BM, Thomas G, Abdella MD. Pregnancy outcome in 211 patients with mild chronic hypertension. Obstet Gynecol Surv 1983;61:571-576.
4. [4] Cunningham FG, MacDonald PC, Leveno KJ, Gant NF, Gilstrap LC. Hypertensive disorders in pregnancy: William Obstetrics. 19th Edition, Appleton and Lange 1993:763-817.
5. [5] Patrignani P, Filabozzi P, Patrono C. Selective cumulative inhibition of platelets thromboxane production by low dose aspirin. J Clin Invest 1982;69:1366-1372.
6. 2 to prostacyclin in relatively high risk pregnancies. N Engl J Med 1989;321:351-356.
7. [7] Sibai BM, Mirro R, Chesley CM et al. Low dose aspirin in pregnancy. Obstet Gynecol 1989;74:551-557.
8. [8] Beaufils M, Uzan S, Donisimoni R, Colau JC. Prevention of pre-eclampsia by early anti-platelet therapy. Lancet 1985;I:840-842.
9. [9] Wallenburg HCS, Dekker GA, Makovitz JW et al. Low dose aspirin prevents pregnancy induced hypertension and pre eclampsia in angiotensin-sensitive primigravida. Lancet 1986;1:1-3.
10. [10] Benigni A, Gregorini G, Frusca T et al. Effect of low dose aspirin on fetal and maternal generation of thromboxane by platelet. N Engl J Med 1989;521:357-362.
11. [11] McParland P, Pearce JM, Chamberlain G. Doppler ultrasound and aspirin in recognition and prevention of pregnancy induced hypertension. Lancet 1990;335: 1552-1555.
12. [12] Italian study. Low dose aspirin in pregnancy in preventing and for treatment of IUGR and pregnancy induced hypertension. Lancet 1993;34:396-400.
13. [13] CLASP. A randomised trial of low dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994;343:619-629.
14. [14] Viinnika L, Hartakainen-Sorri, Lumme R. Low dose aspirin in hypertensive pregnant women. Br J Obstet Gynaecol 1993;100:809-815.
15. [15] Broughton Pipkin F, Crowther C, de Swiet M et al. What next for prophylaxis against preeclampsia. Br J Obstet Gynaecol 1996;103:603-607.
16. [16] Davey D, MacGillivray I. The classification and definition of hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988;158:892-898.
17. [17] Munjanja SP, Masona D. Zimbabwean birthweight for gestation standards Central African. J Med 1990; 36:144-147.
18. [18] Collins R. Antiplatelet drug agents for IUGR and preeclampsia. In: Enkin M, Keirse MJ, Renfrew M, Neilson JP, Editors. Pregnancy and childbirth module. Cochrane Database of Systematic Reviews, Review Number 04000, 1994.
19. [19] ECPPA. A randomised trial of low dose aspirin for the prevention of maternal and fetal complication in high risk pregnant women. Br J Obstet Gynaecol 1996;103:39-47.
20. [20] Byaruhanga RN. A randomised controlled trial of low dose aspirin in women at risk for pre-eclampsia at Harare Central Hospital. Dissertation for Master degree, University of Zimbabwe, 1995.